Preparation method of pharmaceutical grade sodium 3-hydroxybutyrate

By improving the hydrolysis and addition reaction process, combined with acetone crystallization technology, the problem of high impurity content of sodium 3-hydroxybutyrate in the existing technology has been solved, the purity and yield of the product are improved, the production cost is reduced, and the pharmaceutical industry has been realized. High-efficiency preparation of grade 3-hydroxybutyrate.

CN119019245APending Publication Date: 2024-11-26上海康鑫化工有限公司
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411127517.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In the preparation of pharmaceutical grade sodium 3-hydroxybutyrate, the impurity content is high, especially crotonate and heavy metal ions, which are difficult to meet the purity requirements of pharmaceutical grade, resulting in high production costs and low finished product yield.

Method used

By innovating the hydrolysis process and product separation and purification methods, sodium hydroxide and methyl 3-hydroxybutyrate are used to hydrolyze at a specific temperature, alcohol solvents and adducts are added for addition reaction, and combined with acetone crystallization process, it reduces the The formation of crotonate increases the purity and yield of sodium 3-hydroxybutyrate.

Benefits of technology

It significantly reduces the impurity content, improves the purity and total yield of sodium 3-hydroxybutyrate, meets pharmaceutical-grade quality standards, reduces production costs, and is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004996885710000031
    Figure BDA0004996885710000031
  • Figure HDA0004996885720000011
    Figure HDA0004996885720000011
  • Figure HDA0004996885720000021
    Figure HDA0004996885720000021
Patent Text Reader

Abstract

The invention discloses a method for preparing pharmaceutical grade sodium 3-hydroxybutyrate, which comprises the following steps: A. hydrolyzing methyl (ethyl) 3-hydroxybutyrate at 55-60 DEG C by using sodium hydroxide to obtain a sodium 3-hydroxybutyrate crude product; b, dissolving and clarifying the crude product obtained in the step A with methanol and water, adding an addition product, and carrying out heat preservation reaction at 20-30 DEG C to obtain an addition reaction product; c, filtering the reaction liquid in the step B, carrying out reduced pressure distillation on the mother liquid, and evaporating to remove methanol until the mother liquid is thick; adding acetone for crystallization, cooling, filtering and drying to obtain a finished product. The content of crotonic acid in the prepared sodium 3-hydroxybutyrate is not higher than 16 ppm, and the content of the sodium 3-hydroxybutyrate reaches 99.5% or above.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of fine chemicals, and in particular relates to a method for preparing pharmaceutical-grade sodium 3-hydroxybutyrate. Background Art

[0002] Sodium 3-hydroxybutyrate is also called sodium β-hydroxybutyrate, sodium DL-3-hydroxybutyrate, or BHB sodium salt for short. It has been widely used as a dietary supplement ingredient for ketosis. It is a more stable sodium salt supplier than 3-hydroxybutyric acid. For example, it can provide energy for the brain, heart and muscles in the absence of glucose and low carbohydrate intake.

[0003] In recent years, in the medical field, sodium 3-hydroxybutyrate has also been used in the treatment of diseases such as improving and treating brain dysfunction and glutaric aciduria type II.

[0004] The conventional preparation method of sodium 3-hydroxybutyrate is to use 3-hydroxybutyric acid methyl (ethyl) ester as the main raw material, hydrolyze it under the action of sodium hydroxide, and then decolorize, filter press, concentrate, and spray dry to obtain the finished product. However, the main disadvantage of the product prepared by this method is the high impurity content, which is mainly due to the following reasons: 1. In the process of hydrolysis to salt, whether using strong base sodium hydroxide or other sodium salts, crotonate will inevitably be produced, and this by-product will have a certain harmful effect on the human body. 2. The use of conventional chemical raw materials will inevitably introduce some heavy metal ions, causing their content to exceed the standard. 3. When using spray drying, there are many types of impurities and high residues.

[0005] Pharmaceutical grade sodium 3-hydroxybutyrate needs to meet the requirements of high main product content, few impurities, and low heavy metal content. Since the sodium 3-hydroxybutyrate prepared by the existing technology has a high impurity content, it is difficult to meet this basic requirement. Several steps of additional purification process must be carried out before it can be used in medicine. Each step of purification will cause product loss, reduce the overall yield of the finished product, and cause high costs. Summary of the invention

[0006] In order to overcome the above-mentioned defects of the prior art method for preparing high-purity sodium 3-hydroxybutyrate, we innovated the hydrolysis process, and through the control of raw materials and product separation and purification methods, we can prepare pharmaceutical grade sodium 3-hydroxybutyrate products with the shortest process route, and the yield is significantly improved, which significantly reduces the production cost of pharmaceutical grade sodium 3-hydroxybutyrate. Specifically, the present invention provides the following technical solutions.

[0007] A method for preparing pharmaceutical grade sodium 3-hydroxybutyrate comprises the following steps:

[0008] A. Hydrolysis reaction: add methyl (ethyl) 3-hydroxybutyrate, methyl (ethyl) alcohol and water into a reactor; keep the temperature at 15°C-45°C, more preferably 20°C-40°C, more preferably 25°C-30°C, add sodium hydroxide in batches, raise the temperature to 45°C-70°C, preferably 50°C-65°C, more preferably 55°C to 60°C for hydrolysis reaction, cool down to precipitate sodium 3-hydroxybutyrate, filter, wash and dry to obtain crude sodium 3-hydroxybutyrate; wherein, alcohol (methanol or ethanol) can be added together with water. If aqueous alcohol is directly used, such as 95% ethanol, it is not necessary to add water separately.

[0009] B. Addition reaction: add the crude product obtained in step A into a reactor, add appropriate amount of alcohol solvent and water, add the adduct after dissolving, and react at 15°C-40°C, preferably 18°C-35°C, more preferably 20°C-30°C to obtain an addition reaction product;

[0010] C. Purification: Filter the reaction solution of step B to remove a small amount of insoluble matter; distill the mother liquor under reduced pressure to remove alcohol until it becomes thick; add acetone for crystallization, preferably slowly add acetone such as dropwise, stir, cool, filter, and dry to obtain the finished product.

[0011] In one embodiment, the methyl 3-hydroxybutyrate in step A corresponds to the solvent alcohol, that is, methanol is used when the raw material is methyl 3-hydroxybutyrate, and ethanol is used when the raw material is ethyl 3-hydroxybutyrate.

[0012] The adduct in step B is used to catalyze the hydration addition reaction of crotonic acid (butenoic acid), and is selected from sodium bisulfite, sodium sulfite, sodium pyrosulfite, sodium thiosulfate, and a mixture of two or more thereof. More preferably, the adduct is sodium pyrosulfite.

[0013] Preferably, the amount of the adduct in step B is 0.5-0.7 times, for example, about 0.6 times, the purity of crotonic acid detected by HPLC.

[0014] More preferably, in step B, 3-10 times, preferably 4-8 times, more preferably about 5 times the amount of the crude product is used as the solvent, and the reaction is carried out at 20° C.-30° C. Such conditions are conducive to the addition reaction.

[0015] It should be understood that when expressing numerical characteristics in this document, the term "approximately" or "around" means that the number represented may have an error range or floating range of ±10%, ±9%, ±8%, ±7%, ±6% or ±5%.

[0016] The alcohol solvent used in the above step B is selected from methanol, ethanol, isopropanol, isopentyl glycol or a mixture of two or more thereof. More preferably, the alcohol used in step B is methanol.

[0017] Preferably, the HPLC purity of crotonic acid or its salt in the finished sodium 3-hydroxybutyrate obtained in step C is less than 0.32%, and the content determined by external standard method is less than 0.016%; the HPLC purity of sodium 3-hydroxybutyrate is more than 99.2%, and the content determined by external standard method is more than 99.5%.

[0018] The reagents used in the above preparation method include sodium hydroxide (called caustic soda in industry), alcohol solvents such as methanol / ethanol and acetone, which are preferably of food grade or pharmaceutical grade specifications and purity to avoid the introduction of toxic and harmful substances such as heavy metal elements.

[0019] In one embodiment, the organic solvent alcohols such as methanol and acetone used in the above step B and step C are recovered and separated by distillation, and can be reused to achieve the effect of recycling.

[0020] The method can not only efficiently prepare sodium 3-hydroxybutyrate with medical grade safety, but also effectively reduce the production cost of sodium 3-hydroxybutyrate of this specification, and is suitable for industrial production application. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 This is the HPLC spectrum of commercially available food-grade sodium 3-hydroxybutyrate produced by conventional methods. The retention times of the substances in the figure are: 3-hydroxybutyric acid, 4.3min; crotonic acid, 15.4min.

[0022] Figure 2 This is a HPLC spectrum of sodium 3-hydroxybutyrate prepared in one embodiment of the present invention. The retention times of the substances in the figure are: 3-hydroxybutyric acid, 4.3min; crotonic acid, 15.8min. DETAILED DESCRIPTION

[0023] The hydrolysis product of 3-hydroxybutyrate ester, 3-hydroxybutyric acid, contains a hydroxyl group and a carboxyl group and is highly active. Under weakly alkaline conditions, it is easy to remove the hydroxyl group to form crotonic acid, which is a toxic substance that seriously affects the quality of 3-hydroxybutyric acid and 3-hydroxybutyrate salts.

[0024] The sodium 3-hydroxybutyrate product produced by conventional methods (e.g., methods including a spray drying step) has a relatively high impurity content, including a relatively high content of crotonate. Figure 1 , taking a batch of products produced in large quantities, the purity of crotonate determined by HPLC was 4.877%, and its content determined by external standard method was 0.244%. The purity of sodium 3-hydroxybutyrate was 94.074%, and its content determined by external standard method was 98.35%.

[0025] Considering that crotonic acid (butenoic acid) seriously affects the use of sodium 3-hydroxybutyrate as medicine and is a harmful main by-product, the design idea of ​​the present invention is to avoid the production of impurity crotonic acid (butenoic acid) salt, reduce the residual impurities in the finished product, and use a crystallization process instead of spray drying that requires a higher temperature.

[0026] To this end, we conceived the idea of ​​utilizing the principle of reversible reaction chemical equilibrium to replenish the intermediate reactant through an addition reaction that can lead to the reverse reaction of crotonic acid (butyric acid) to produce 3-hydroxybutyric acid, as shown in the following reaction formula.

[0027]

[0028] That is, the method for reducing the crotonic acid (butenoic acid) salt is to add a certain amount of adduct, which can convert the generated byproduct crotonate into 3-hydroxybutyrate, thereby achieving the purpose of reducing crotonate. The adduct is also called an addition catalyst, which is used to catalyze the hydration addition reaction of crotonic acid (butenoic acid), including but not limited to sodium bisulfite, sodium sulfite, sodium pyrosulfite, sodium thiosulfate and a mixture of two or more thereof, more preferably sodium pyrosulfite.

[0029] The design idea of ​​this process is to mix the crude product of the hydrolysis reaction with an appropriate solvent, dissolve it, add an adduct, and reversely convert the crotonic acid formed by dehydroxylation of 3-hydroxybutyric acid into 3-hydroxybutyric acid, and then generate its sodium salt.

[0030] The catalysis of the above adduct makes the degree of olefin hydration reaction of crotonic acid controllable. The crotonic acid addition product prepared by the adduct catalysis does not contain other by-products such as sodium 2-hydroxybutyrate, sodium 3-ketobutyrate, sodium 2-ketobutyrate, etc., at least no other by-products can be detected by HPLC.

[0031] In the purification or refining of the hydrolysis / addition reaction product sodium 3-hydroxybutyrate, through comparison of a number of organic solvent aids that can promote the crystallization of the product sodium 3-hydroxybutyrate, it was found that the use of acetone as a crystallization aid has the best effect, the highest yield of pure products, and can remove more impurities and improve the purity of the finished product.

[0032] Herein, the term "impurities (in the product)" should be understood in a broad sense, and is not limited to the main by-product crotonic acid (salt), but also includes impurities such as heavy metal elements in the raw materials. The "impurities" described in the product sodium 3-hydroxybutyrate even include unreacted raw materials themselves, such as methyl (ethyl) 3-hydroxybutyrate.

[0033] As used herein, the terms "(purity) improvement", "enhancement" or "increase" may mean an increase of at least 10% compared to a reference level (such as a prior art process product), for example, an increase of at least about 20%, or at least about 30%, or at least about 40%, or at least about 50%, or at least about 60%, or at least about 70%, or at least about 80%, or at least about 90%, or up to and including an increase of 100% compared to a reference level.

[0034] Accordingly, as used herein, the terms "(impurities such as crotonic acid content) decrease", "reduction" or "reduction" may mean a decrease of at least 10% compared to a reference level (such as a product of a prior art process), for example, a decrease of at least about 20%, or at least about 30%, or at least about 40%, or at least about 50%, or at least about 60%, or at least about 70%, or at least about 80%, or at least about 90%, or up to and including a 100% decrease, or any decrease between 10% and 100%, or an increase of at least about 2 times, or at least about 3 times, or at least about 4 times, or at least about 5 times, or at least about 10 times compared to a reference level.

[0035] The sodium 3-hydroxybutyrate prepared by the process of the present invention has a purity of crotonate of less than 0.311% determined by HPLC, and a content of less than 0.016% determined by an external standard method, i.e., less than 16 ppm; the HPLC purity of the sodium 3-hydroxybutyrate reaches more than 99.288%, and the content of the sodium 3-hydroxybutyrate reaches more than 99.56%, which meets the pharmaceutical-grade quality standards formulated by the enterprise.

[0036] The term "pharmaceutical grade" in this article can also be referred to as "medical grade" or "pharmaceutical grade". They have the same meaning and can be used interchangeably. They all refer to the safety of the product meeting the safety standards for injectable and / or oral medications, which is higher than food grade.

[0037] As a specific embodiment, the preparation method of the present invention generally comprises the following steps:

[0038] A. Hydrolysis reaction: Add 3-hydroxybutyric acid ethyl ester, ethanol and water into the reactor; keep the temperature at 25°C-30°C, add sodium hydroxide in batches, react at 55°C to 60°C, cool down to precipitate sodium 3-hydroxybutyrate, filter, wash and dry to obtain crude sodium 3-hydroxybutyrate. Alternatively, if aqueous ethanol such as 95% ethanol is used directly, no additional water needs to be added.

[0039] B. Addition reaction: add the crude product obtained in step A into a reactor, add appropriate amount of alcohol and water, after dissolving, add the adduct, and react at 20℃-30℃ to obtain the addition reaction product;

[0040] C. Purification: Filter the reaction solution of step B to remove a small amount of insoluble matter; distill the mother liquor under reduced pressure to evaporate methanol until it becomes thick; slowly add acetone dropwise for crystallization, stir, cool, filter, and dry.

[0041] In the above addition reaction step, the alcohol used is particularly preferably methanol. Compared with other alcohols such as ethanol, isopropanol, isopentyl glycol, etc., using methanol to promote the addition reaction can significantly reduce the production of crotonic acid (butyric acid) salt.

[0042] The organic solvents methanol and acetone used in the above step B and step C can be recovered, separated by distillation, and reused to achieve the effect of recycling.

[0043] The reagents used in the above preparation method include sodium hydroxide (called flake caustic soda in industry), methanol / ethanol and acetone, all of which are preferably of food grade specifications and purity, preferably pharmaceutical grade, to avoid the introduction of toxic and harmful substances such as heavy metal elements.

[0044] Starting from the experimentally pure 3-hydroxybutyric acid methyl (ethyl) ester, the total yield of pharmaceutical-grade sodium 3-hydroxybutyrate prepared by the process of the present invention can reach more than 80%, which is much higher than the total yield (about 61%) of conventional preparation methods and purification processes, and does not require high-energy-consuming spray drying, thereby avoiding the investment in production equipment such as a spray drying tower and a matching cyclone separator, the investment in a production site, etc., which helps to greatly reduce the production cost of pharmaceutical sodium 3-hydroxybutyrate and significantly improves the economic efficiency.

[0045] Those skilled in the art will readily appreciate that the addition backfilling technology of the present invention is also applicable to other pharmaceutical grade 3-hydroxybutyrate metal salts of the same type of product, such as calcium 3-hydroxybutyrate, magnesium 3-hydroxybutyrate, potassium 3-hydroxybutyrate, zinc 3-hydroxybutyrate, iron 3-hydroxybutyrate, and the like.

[0046] It should be understood that in order to ensure the food and medicinal safety of the sodium 3-hydroxybutyrate product, the inorganic raw material flake caustic soda and the organic solvents ethanol, methanol, acetone, etc. approved for use by the State Food and Drug Administration and FDA are preferably food safety grade raw materials.

[0047] Example

[0048] The present invention is further described below by examples. It should be understood that these examples are only for illustrative purposes, rather than limiting the present invention. Various changes or adjustments made by those skilled in the art based on the present invention should all fall within the scope of protection of the present invention.

[0049] This article involves the addition amount, content and concentration of various substances, and the percentages mentioned here refer to the mass percentages unless otherwise specified.

[0050] In the embodiments herein, if no specific description is given for the operating temperature, the temperature generally refers to room temperature (15-35° C.).

[0051] HPLC detection method of sodium 3-hydroxybutyrate in the embodiment:

[0052] Instrument: Liquid chromatograph Agilent 1260

[0053] Chromatographic column: Agilent ZORBAX SB-Aq 4.6mm×250mm×5μm or equivalent

[0054] Mobile phase: 0.1% perchloric acid aqueous solution: acetonitrile = 95:5 (v / v);

[0055] Flow rate: 1.0ml / min

[0056] Column temperature: 30°C

[0057] Detector: Differential refractive index detector

[0058] Detection wavelength: 214nm

[0059] Injection volume: 10 μl

[0060] The content of ingredients was calculated by external standard method.

[0061] Enterprise quality standards:

[0062] The pharmaceutical-grade quality standards we have established are: sodium 3-hydroxybutyrate content ≥ 99.0%; total impurities ≤ 1.0%, of which: crotonic acid residue ≤ 0.05%, i.e. not higher than 50ppm.

[0063] Example 1: Preparation of crude sodium 3-hydroxybutyrate

[0064] In a 500ml three-necked flask, add 50g (0.378mol) of ethyl 3-hydroxybutyrate and 250ml of 95% ethanol, stir and dissolve. Keep the temperature at 25-30℃, and add 15.1g of sodium hydroxide (0.378mol) in batches within 4 hours. After the addition of sodium hydroxide, raise the temperature to 55-60℃ until the system is dissolved and react for 3 hours. Cool down to 10℃, filter, and dry at 80℃. Take a sample, and the purity of crotonic acid detected by HPLC is 2.869%, and the weight yield of dry product is 81%. This is the crude product of sodium 3-hydroxybutyrate.

[0065] Example 2: Addition reaction and purification

[0066] In a 500 ml three-necked flask, add 20 g of the crude product obtained in Example 1, then add 100 ml of methanol and 3 ml of deionized water, and heat to 25° C. After dissolving, add 1.5 g of sodium pyrosulfite and keep the temperature at 23° C. for 5 hours.

[0067] Filter and remove a small amount of insoluble matter. The mother liquor was distilled under reduced pressure to evaporate methanol until it became thick. Slowly drop 100 ml of acetone to crystallize, keep warm and stir for 0.5 hours, cool to 10°C, keep warm for 1 hour, filter and dry at 80°C. The dry product weight yield was 0.92, the purity of crotonic acid was 0.189% by HPLC, and its content was 0.009% by external standard method.

[0068] Example 3: Addition reaction and purification

[0069] In a 500 ml three-necked flask, add 20 g of the crude product obtained in Example 1, then add 100 ml of 95% methanol, and heat to 25° C. After dissolving, add 1.5 g of sodium pyrosulfite, and keep the temperature at 25° C. for 5 hours.

[0070] Filter and remove a small amount of insoluble matter. The mother liquor was distilled under reduced pressure to evaporate methanol until it became thick. Slowly drop 100 ml of acetone to crystallize, keep warm and stir for 0.5 hours, cool to 10°C, keep warm for 1 hour, filter and dry at 80°C. The dry product weight yield was 0.91, the purity of crotonic acid was 0.311% by HPLC, and its content was 0.016% by external standard method.

[0071] Example 4: Addition reaction and purification

[0072] In a 500ml three-necked flask, add 20g of the crude product and 100ml of methanol, and heat to 30°C. After dissolving, add 1.5g of sodium pyrosulfite and keep the temperature at 30°C for 5 hours.

[0073] Filter and remove a small amount of insoluble matter. The mother liquor is distilled under reduced pressure to evaporate methanol until it becomes thick. Slowly add 100 ml of acetone to crystallize, keep warm and stir for 0.5 hours, cool to 10°C, keep warm for 1 hour, filter and dry at 80°C. The dry product weight yield is 90%, the purity of crotonic acid is 0.333% by HPLC, and its content is 0.017% by external standard method.

[0074] Example 5: Addition reaction and purification

[0075] In a 500 ml three-necked flask, add 20 g of the crude product and then add 100 ml of 95% ethanol, and heat to 25° C. After dissolving, add 1.5 g of sodium pyrosulfite and keep the temperature at 25° C. for 5 hours.

[0076] Filter and remove a small amount of insoluble matter. The mother liquor was distilled under reduced pressure to evaporate methanol until it became thick. Slowly drop 100 ml of acetone to crystallize, keep warm and stir for 0.5 hours, cool to 10°C, keep warm for 1 hour, filter and dry at 80°C. The dry product weight yield was 91%, the purity of crotonic acid was 0.231% by HPLC, and its content was 0.011% by external standard method.

[0077] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing pharmaceutical grade sodium 3-hydroxybutyrate, characterized in that: The steps include: A. Hydrolysis reaction: add methyl (ethyl) 3-hydroxybutyrate, methyl (ethyl) alcohol and water into a reactor; keep the temperature at 15°C-45°C, more preferably 20°C-40°C, more preferably 25°C-30°C, add sodium hydroxide in batches, raise the temperature to 45°C-70°C, preferably 50°C-65°C, more preferably 55°C to 60°C for hydrolysis reaction, cool down to precipitate sodium 3-hydroxybutyrate, filter, wash and dry to obtain crude sodium 3-hydroxybutyrate; B. Addition reaction: add the crude product obtained in step A to a reactor, add an alcohol solvent and water, and after dissolving, add the adduct, and react at 15°C-40°C, preferably 18°C-35°C, more preferably 20°C-30°C to obtain an addition reaction product; C. Purification: Filter the reaction solution of step B to remove a small amount of insoluble matter; distill the mother liquor under reduced pressure to remove alcohol; add acetone for crystallization, stir, cool, filter, and dry to obtain the finished product.

2. The method according to claim 1, characterized in that The methyl 3-hydroxybutyrate in step A corresponds to the solvent alcohol, that is, methanol is used when the raw material is methyl 3-hydroxybutyrate, and ethanol is used when the raw material is ethyl 3-hydroxybutyrate.

3. The method according to claim 1, characterized in that The adduct in step B is selected from sodium bisulfite, sodium sulfite, sodium pyrosulfite, sodium thiosulfate and a mixture of two or more thereof.

4. The method according to claim 1, characterized in that The adduct in step B is sodium pyrosulfite.

5. The method according to claim 3, characterized in that The dosage of the adduct is 0.5-0.7 times the purity of the crotonic acid detected by HPLC.

6. The method according to claim 3, characterized in that In step B, the amount of solvent is 3-10 times, preferably 4-8 times, more preferably 5 times the amount of the crude product, and the reaction is carried out at 20°C-30°C.

7. The method according to claim 1, characterized in that The alcohol solvent used in step B is selected from methanol, ethanol, isopropanol, isopentyl glycol or a mixture of two or more thereof.

8. The method according to claim 1, characterized in that The alcohol used in step B is methanol.

9. The method according to claim 1, characterized in that The HPLC purity of crotonic acid or its salt in the sodium 3-hydroxybutyrate product obtained in step C is less than 0.32%, and the content determined by external standard method is less than 0.016%; the HPLC purity of sodium 3-hydroxybutyrate is more than 99.2%, and the content determined by external standard method is more than 99.5%.

10. The method according to claim 1, characterized in that The reagents used in the preparation method, including sodium hydroxide, alcohol solvent and acetone, all adopt food grade or pharmaceutical grade specifications and purity.

Citation Information

Cited By

  • Preparation method of D-3-hydroxybutyric acid and ketogenic effervescent tablet

    CN120698868A

  • Preparation method for pharmaceutical-grade sodium 3-hydroxybutyrate

    WO2026037308A1